What is the official website of Sartorius | CellCelector – Automated Cell Selection and Retrieval ?

The official website of Sartorius | CellCelector – Automated Cell Selection and Retrieval is https://www.sartorius.com/en/products/cell-selection-and-retrieval.

Has Sartorius | CellCelector – Automated Cell Selection and Retrieval been affected by any supply chain cyber incidents ?

According to Rankiteo, Sartorius | CellCelector – Automated Cell Selection and Retrieval has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sartorius | CellCelector – Automated Cell Selection and Retrieval have PCI DSS certification ?

According to Rankiteo, Sartorius | CellCelector – Automated Cell Selection and Retrieval does not currently maintain PCI DSS compliance.

Does Sartorius | CellCelector – Automated Cell Selection and Retrieval have ISO 27001 certification ?

According to Rankiteo,Sartorius | CellCelector – Automated Cell Selection and Retrieval is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

How many LinkedIn followers does Sartorius | CellCelector – Automated Cell Selection and Retrieval have ?

Sartorius | CellCelector – Automated Cell Selection and Retrieval's official LinkedIn profile has approximately 1,261 followers.

What is the NAICS classification code for Sartorius | CellCelector – Automated Cell Selection and Retrieval ?

Sartorius | CellCelector – Automated Cell Selection and Retrieval is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Sartorius | CellCelector – Automated Cell Selection and Retrieval have a Crunchbase profile ?

No, Sartorius | CellCelector – Automated Cell Selection and Retrieval does not have a profile on Crunchbase.

How many peer or competitor companies does Sartorius | CellCelector – Automated Cell Selection and Retrieval have ?

Sartorius | CellCelector – Automated Cell Selection and Retrieval has an estimated 4,757 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

SCACSR

Boost Score +25 with badge (5 left)

748

/1000

Moderate

773

/1000

Fair

Sartorius | CellCelector – Automated Cell Selection and Retrieval Vendor Cyber Rating & Cyber Score

sartorius.com

Add Your Compliance Badge

Sartorius is a leading international partner of life science research and the biopharmaceutical industry. Our ambition is to simplify progress in biopharmaceutical research and production. We support our customers with innovative technologies that make the development and manufacture of therapeutics faster and more efficient, giving people access to better medicine. Over 15,000 employees at over 60 production and sales locations worldwide are committed to this vision. In 2022, Sartorius expanded its BioAnalytics portfolio by acquiring a majority stake in Automated Lab Solutions (ALS), enabling life science customers to significantly reduce time and costs in single-cell isolation, stem cells, cell line development and antibody discovery

SCACSR A.I CyberSecurity Scoring

Scoring History

SCACSR

Sartorius | CellCelector – Automated Cell Selection and Retrieval CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

SCACSR Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for SCACSR

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Sartorius | CellCelector – Automated Cell Selection and Retrieval in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sartorius | CellCelector – Automated Cell Selection and Retrieval in 2026.

Incident Types SCACSR vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Sartorius | CellCelector – Automated Cell Selection and Retrieval in 2026.

Incident History - SCACSR (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sartorius | CellCelector – Automated Cell Selection and Retrieval Subsidiaries

SCACSR

Biotechnology Research

Website: https://www.sartorius.com/en/products/cell-selection-and-retrieval

Company Size: 10,001+ employees

SartoriusBiotechnology Research

Octet®- Affinity, Binding Kinetics and ConcentrationBiotechnologieforschung

Sartorius Stedim BiotechBiotechnology Research

Lab Essentials for Research and DevelopmentBiotechnologieforschung

Incucyte® - Live-Cell Analysis SystemsBiotechnologie

Loading…

Sartorius | CellCelector – Automated Cell Selection and Retrieval Similar Companies

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Loading…

NEWS

Sartorius | CellCelector – Automated Cell Selection and Retrieval CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-86304

SUMMARY

MojoX::Authentication versions before 0.006 for Perl allow SAML authentication bypass because parse_assertion builds Net::SAML2::Binding::POST without a trust anchor. parse_assertion in MojoX::Authentication::Model::SAML2 calls Net::SAML2::Binding::POST->new with no cacert, cert_text or anchors argument, then passes the returned XML to Net::SAML2::Protocol::Assertion->new_from_xml with the IdP signing certificate as cacert. In Net::SAML2 before 0.86 that certificate guards only encrypted assertions, so the signature on an unencrypted assertion is checked against the certificate the response itself carries. An attacker starts a SAML login, then posts a response signed with a certificate of their own. The audience, InResponseTo and timestamp checks that follow are all satisfiable by the attacker, so the response authenticates any NameID it carries.

Published

Date2026-09-06

Updated

Date2026-09-06

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-86232

SUMMARY

A weakness has been identified in itsourcecode Sales and Inventory System 1.0. Affected by this vulnerability is an unknown functionality of the file /pages/sup_del.php?type=supplier. Executing a manipulation of the argument ID can lead to sql injection. The attack may be performed from remote. The exploit has been made available to the public and could be used for attacks.

Published

Date2026-09-06

Updated

Date2026-09-06

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-86231

SUMMARY

A security flaw has been discovered in mwiede jsch up to 2.28.5. Affected is the function getRevokedKeys of the file src/main/java/com/jcraft/jsch/KnownHosts.java. Performing a manipulation of the argument known_hosts results in improper check for certificate revocation. The attack is possible to be carried out remotely. The attack is considered to have high complexity. The exploitability is told to be difficult. The exploit has been released to the public and may be used for attacks. Upgrading to version 2.28.6 is able to address this issue. The patch is named 194a2f76a5c0f1c3f778565be3fd66bcafc42d23. You should upgrade the affected component.

Published

Date2026-09-06

Updated

Date2026-09-06

RISK INFORMATION (Score: 3.7)

cvss2

Base Score: 2.6

Complexity: HIGH

AV:N/AC:H/Au:N/C:N/I:P/A:N

cvss3

Base Score: 3.7

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:L/A:N

cvss4

Base Score: 2.9

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.2

REFERENCES

CVE-2026-86228

SUMMARY

A security vulnerability has been detected in JeecgBoot up to 3.9.3. This vulnerability affects the function exportXls of the file jeecg-boot/jeecg-boot-module/jeecg-boot-module-airag/src/main/java/org/jeecg/modules/airag/llm/controller/AiragModelController.java. Such manipulation of the argument credential leads to improper access controls. It is possible to launch the attack remotely. The exploit has been disclosed publicly and may be used. Upgrading to version 3.9.5 is able to resolve this issue. The name of the patch is a2be896f753936956ee6863b632b8e5a0231345c. You should upgrade the affected component.

Published

Date2026-09-06

Updated

Date2026-09-06

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-86227

SUMMARY

A weakness has been identified in valkey-io valkey up to 9.0.5/9.1.1. This affects the function kvstoreGetHashtable of the file src/kvstore.c. This manipulation of the argument didx causes out-of-bounds read. It is possible to initiate the attack remotely. The attack is considered to have high complexity. It is indicated that the exploitability is difficult. The exploit has been made available to the public and could be used for attacks. Patch name: 4691888e7fab3df128f0bde5750c9fde2ae552fa. To fix this issue, it is recommended to deploy a patch. Exploitation requires cluster mode plus attacker-controlled dump.rdb at startup (data-dir write access, replication feed, or a stored crafted RDB) - an attacker-position DoS at boot, not network pre-auth. The issue report was closed stating it "is worth fixing for the sake of memory safety… but I don't think it meets our bar for a security disclosure."

Published

Date2026-09-06

Updated

Date2026-09-06

RISK INFORMATION (Score: 3.1)

cvss2

Base Score: 2.1

Complexity: HIGH

AV:N/AC:H/Au:S/C:N/I:N/A:P

cvss3

Base Score: 3.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 1.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

1.6

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…